India Capital Growth (IGC) Share Price, News & Analysis

Company Overview

Fund Objective: To provide long term capital appreciation by investing predominantly in listed mid and small cap Indian companies. Investments may also be made in large cap Indian companies where the Fund Manager believes long-term capital appreciation will be achieved. The Company may hold liquid assets (including cash) pending deployment in suitable investments. It is the Company’s declared policy not to hedge the exposure to the Indian Rupee.

Key Stats

• Today's Range: 171 to 175.50
• 50-Day Range: 150.50 to 177.50
• 52-Week Range: 139 to 199
• Volume: 127,801 shs
• Average Volume: 275,729 shs
• Market Capitalization: £148.94 million
• P/E Ratio: 3.48
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

IGC Stock Analysis - Frequently Asked Questions

How have IGC shares performed this year?

India Capital Growth's stock was trading at GBX 192.50 on January 1st, 2025. Since then, IGC shares have decreased by 10.4% and is now trading at GBX 172.50.
View the best growth stocks for 2025 here.

How were India Capital Growth's earnings last quarter?

India Capital Growth (LON:IGC) posted its quarterly earnings results on Friday, March, 28th. The company reported $27.04 earnings per share (EPS) for the quarter. India Capital Growth had a net margin of 93.35% and a trailing twelve-month return on equity of 25.12%.

How do I buy shares of India Capital Growth?

Shares of IGC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of India Capital Growth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that India Capital Growth investors own include Meta Platforms (META), Tilray (TLRY), JinkoSolar (JKS), Nikola (NKLA), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD) and Alibaba Group (BABA).

Company Calendar

• Last Earnings: 3/28/2025
• Today: 6/16/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: Pharmaceutical Products
• Current Symbol: LON:IGC
• CIK: N/A
• Web: www.indiacapitalgrowth.com
• Phone: 44 20 7068 9870
• Fax: N/A
• Employees: 61
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 49.52
• Trailing P/E Ratio: 3.48
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £43.14 million
• Net Margins: 93.35%
• Pretax Margin: N/A
• Return on Equity: 25.12%
• Return on Assets: 15.98%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 23.31
• Quick Ratio: 6.26

Sales & Book Value

• Annual Sales: £46.21 million
• Price / Sales: 3.22
• Cash Flow: GBX 1.77 per share
• Price / Cash Flow: 97.31
• Book Value: GBX 198.57 per share
• Price / Book: 0.87

Miscellaneous

• Outstanding Shares: 86,339,198
• Free Float: N/A
• Market Cap: £148.94 million
• Optionable: Not Optionable
• Beta: 0.70